Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: A quantitative study of factors associated with decision-making

Paudyal, Vibhu; Hansford, Denise; Cunningham, Scott; Stewart, Derek

doi:10.1016/j.sapharm.2013.04.007

Cited by 8 publications

(3 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmacists have been traditionally offering services for self-care and common ailments including supply of non-prescription medicines. 55 , 56 , 57 It is imperative that counselling and communications practices by healthcare professionals, including pharmacists, in regards to CAM use are evidence based. Phytochemicals have been integrated into the treatment of long-term health conditions such as cancer and gout.…”

Section: Discussionmentioning

confidence: 99%

Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research

Paudyal

Sun

Hussain

et al. 2022

Research in Social and Administrative Pharmacy

Self Cite

View full text Add to dashboard Cite

The COVID-19 pandemic has met international health systems with a low level of preparedness and emergency response. While the emergence of effective vaccines has offered the Governments, scientific communities, and members of the public a possible way out of the pandemic, effective pharmacotherapy, including immunotherapy for COVID-19 prevention and treatment, are yet to be established. Internationally, this has led to a surge in the demand and supply of many complementary and alternative medicines (CAM) and practices. Recent studies have shown increasing CAM information requests made to pharmacists and other healthcare staff from members of public and patients aimed at prevention, symptoms relief or treatment of COVID-19. In this context, it is imperative that healthcare professionals, including pharmacists, are acquainted with current practices, policies, and research in relation to CAM use in COVID-19. This narrative commentary will provide an update on global practices, policies and research in regards to CAM use in the context of COVID-19. Healthcare professionals’ understanding of popular CAMs and those tipped for potential benefits in COVID-19, patient and consumer behaviors in relation to CAM use; and healthcare professionals' awareness of cultural, religious, and self-care practices associated with CAM use are imperative to inform effective communication and counselling practices and promote evidence based self-care when patients present for advice. This narrative provides relevant discussions specific to different continents and regions historically linked to diverse CAM practices.

show abstract

Section: Discussionmentioning

confidence: 99%

Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research

Paudyal

Sun

Hussain

et al. 2022

Research in Social and Administrative Pharmacy

Self Cite

View full text Add to dashboard Cite

show abstract

“…5 Pharmacists often welcome this development. [6][7][8] However, some potential reclassifications do not actualize. In the United States (US) in 2012 the Food and Drug Administration (FDA) suggested that reclassifing medicines could alleviate under-treatment of conditions like hypertension and asthma, 9 but no such reclassifications have been forthcoming.…”

Section: Medicines Reclassification From a Pharmaceutical Industry Pementioning

confidence: 99%

Medicines reclassification from a pharmaceutical industry perspective: An international qualitative study

Gauld

Kelly

Emmerton

et al. 2019

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

“…They will have insights into supplies through pharmacy and perspectives on the risks and benefits that could provide useful information to committees considering these reclassifications. However, pharmacist surveys for their opinions on reclassifications are usually for prescription to non-prescription reclassifications [ 1 , 2 , 3 , 4 ] and not for pharmacy-only to general sales.…”

Section: Introductionmentioning

confidence: 99%

Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences

Gauld

Sullivan²

2018

Pharmacy

View full text Add to dashboard Cite

The aim of this paper was to explore pharmacists’ views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists’ views on the reclassification of the shingles vaccine and sildenafil to be available through ‘accredited’ pharmacists. New Zealand community pharmacists were surveyed in 2013 with a written questionnaire of six Likert-style or open-ended questions sent to Pharmacy Guild member pharmacies. The analysis involved descriptive statistics. Responses were received from 246 pharmacies. Two thirds of pharmacists supported the reclassification of the shingles vaccine and sildenafil, although 14% disagreed with the sildenafil reclassification. Over 90% of pharmacists disagreed with the reclassification of paracetamol and ibuprofen liquids, omeprazole, naproxen, and oxymetazoline from pharmacy-only medicine to general sales. This opinion was strongest for omeprazole. With liquid paracetamol and ibuprofen, pharmacists described consumer confusion with dosing, and particularly potentially doubling-up on liquid analgesics/antipyretics including using both prescription and non-prescription variants. Many reported giving safety advice frequently. Anti-inflammatories and omeprazole were also subject to potential double-dosing, as well as requests by consumers with contraindications, precautions, and drug interactions, and for inappropriate indications. Pharmacists described various interventions, including some that were potentially life-saving. Pharmacy availability of medicines provides the potential for intervention that would not happen in a general sales environment.

show abstract

Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: A quantitative study of factors associated with decision-making

Cited by 8 publications

References 37 publications

Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research

Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research

Medicines reclassification from a pharmaceutical industry perspective: An international qualitative study

Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences

Contact Info

Product

Resources

About